Joo Yong Hahn

Summary

Affiliation: Sungkyunkwan University
Country: Korea

Publications

  1. Jang W, Ahn S, Song Y, Choi S, Chun W, Oh J, et al. Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II. Circ Cardiovasc Interv. 2018;11:e005849 pubmed publisher
    ..Our results suggest that prolonged DAPT may improve long-term clinical outcomes after percutaneous coronary intervention for bifurcation lesions. URL: https://www.clinicaltrials.gov. Unique identifier: NCT01642992. ..
  2. Gwag H, Kim E, Park T, Lee J, Yang J, Song Y, et al. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial. J Am Heart Assoc. 2017;6: pubmed publisher
    ..URL: http://www.clinicaltrials.gov. Unique identifier: NCT01738100. ..
  3. Choi K, Song Y, Lee J, Lee S, Park T, Yang J, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC Cardiovasc Interv. 2019;: pubmed publisher
    ..Use of IVUS should be actively considered for complex PCI. ..
  4. Song P, Park K, Kim M, Jeon K, Park J, Choi R, et al. Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention. Korean Circ J. 2019;49:69-80 pubmed publisher
    ..095; p=0.074) did not differ between 2 stent groups after complex PCI. Clinical outcomes of BP-BES were comparable to those of DP-EES at 2 years after complex PCI. Our data suggest that use of BP-BES is acceptable, even for complex PCI. ..
  5. Cho S, Park K, Ahn J, Park T, Lee S, Kim J, et al. Extended Clopidogrel Therapy Beyond 12 Months and Long-Term Outcomes in Patients With Diabetes Mellitus Receiving Coronary Arterial Second-Generation Drug-Eluting Stents. Am J Cardiol. 2018;122:705-711 pubmed publisher
    ..In conclusion, our data suggest that the benefits of extended clopidogrel therapy are more prominent in diabetic patients receiving second-generation DES implantation compared with nondiabetic patients. ..
  6. Yang J, Hahn J, Song Y, Choi S, Choi J, Lee S, et al. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study. BMJ. 2014;349:g6650 pubmed publisher
    ..Angiotensin receptor blockers could be used as an alternative to ACE inhibitors in such patients. ..
  7. Song P, Hahn J, Kim D, Song Y, Choi S, Choi J, et al. Duration of clopidogrel-based dual antiplatelet therapy and clinical outcomes after endeavor sprint zotarolimus-eluting stent implantation in patients presenting with acute coronary syndrome. Eur J Intern Med. 2015;26:521-7 pubmed publisher
    ..DAPT for >6months do not seem to be associated with improved clinical outcomes in patients with ACS undergoing percutaneous coronary intervention (PCI) with ZES. ..
  8. Hahn J, Yu C, Park H, Song Y, Kim E, Lee H, et al. Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial. Am Heart J. 2015;169:639-46 pubmed publisher
    ..46-3.85, P = .59) did not differ significantly between the 2 groups. Ischemic postconditioning does not seem to improve the 1-year clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary PCI. ..
  9. Jang W, Park Y, Hahn J, Song Y, Choi S, Chun W, et al. Differential effect of side branch intervention on long-term clinical outcomes according to side branch stenosis after main vessel stenting: Results from the COBIS (Coronary Bifurcation Stenting) Registry II. Int J Cardiol. 2016;221:471-7 pubmed publisher
    ..36; 95% CI 0.58-3.20; P=0.48). The effect of SB intervention differed according to SB stenosis after MV stenting. SB intervention may reduce cardiac death or MI in bifurcation lesions with diameter stenosis of SB ?50% after MV stenting. ..

More Information

Publications14

  1. Song Y, Oh S, Oh J, Im E, Cho D, Cho B, et al. Rationale and design of the comparison between a P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients undergoing implantation of coronary drug-eluting stents (SMART-CHOICE): A prospective multicenter randomized trial. Am Heart J. 2018;197:77-84 pubmed publisher
  2. Lee J, Rhee T, Hahn J, Kim H, Park J, Hwang D, et al. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock. J Am Coll Cardiol. 2018;71:844-856 pubmed publisher
    ..Our data suggest that multivessel PCI for complete revascularization is a reasonable strategy to improve outcomes in patients with STEMI with cardiogenic shock. ..
  3. Lee J, Cho D, Hahn J, Song Y, Park T, Oh J, et al. Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Th. Am Heart J. 2016;182:1-8 pubmed publisher
    ..The SMART-DATE randomized trial is the first study exploring the safety of 6-month DAPT compared with conventional 12-month or longer DAPT dedicated to patients with ACS after second-generation drug-eluting stent implantation. ..
  4. Lee J, Rhee T, Chang H, Ahn C, Park T, Yang J, et al. Deferred versus conventional stent implantation in patients with acute ST-segment elevation myocardial infarction: An updated meta-analysis of 10 studies. Int J Cardiol. 2017;230:509-517 pubmed publisher
  5. Hwang J, Lee S, Song Y, Ahn J, Carriere K, Jang M, et al. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus. Circ Cardiovasc Interv. 2017;10: pubmed publisher
    ..Our data suggest that high HbA1c levels 2 years after percutaneous coronary intervention may identify a population at increased risk of adverse events, especially repeat revascularization. ..